[New therapeutic approaches to Alzheimer's disease].
de Ladoucette
Oliver
O
Chargé de cours a l'Université Paris.
D000544:Alzheimer Disease / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D017690:Cell Transplantation; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D020441:Ginkgo biloba; D006801:Humans; D007116:Immunization, Passive; D009414:Nerve Growth Factors / Q000627:therapeutic use; D009473:Neuronal Plasticity / Q000187:drug effects; D008517:Phytotherapy; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D012106:Research / Q000458:organization & administration; D016896:Treatment Outcome; D014611:Vaccination
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D002800:Cholinesterase Inhibitors; D015525:Fatty Acids, Omega-3; D009414:Nerve Growth Factors; D016194:Receptors, N-Methyl-D-Aspartate